Tanalys

PolarCool signs a strategic agreement with Neurovision Sport and Performance clinic

The med-tec company PolarCool AB (publ.) has formed a strategic partnership with the French-based clinic Neurovisoin Sport and Performance. The clinic specializes in concussion evaluation and treatment of sport-related concussions and will integrate PolarCap® into its protocols.

PolarCool develops and markets the product PolarCap®, which alleviates the effects of concussions. The primary users of PolarCap® include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, football, and handball, but also other sports with an increased risk of concussion.

Neurovision, under the guidance of Neuroscience Clinician and Orthoptist Romain Bordas, specializes in evaluating perceptual and cognitive deviations in athletes who have suffered sports-related concussions. The clinic employs a comprehensive approach to treatment, gradually retraining and reactivating athletes’ brains to alleviate symptoms and facilitate a return to both sports and normal life.

With established partnerships, Neurovision extends its expertise to professional athletes, teams, and organizations across various sports sectors in France, Switzerland, and the EU. The collaboration between PolarCool and Neurovision involves the integration of PolarCap® into the clinic’s concussion recovery protocols. This strategic partnership will showcase and provide exposure for the PolarCap® System as treatment among top athletes, teams, and organizations.

PolarCool’s CEO Erik Andersson comments;

-We are delighted to announce a collaboration with Neurovision Sport and Performance and look forward providing a PolarCap® System to this globally acclaimed clinic. This partnership not only underscores our commitment to improving concussion treatment but also highlights the potential of the PolarCap® System to be used within clinics and healthcare practices.

The agreement with Neurovision Sport and Performance is strategically important, even if the financial significance of individual agreements is limited.

For more information

Erik Andersson –  CEO PolarCool AB (publ.)               
+46 – 738 60 57 00                                         
E-mail: erik.andersson@polarcool.se
 

About PolarCool AB (publ.)

PolarCool AB (publ.) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ.) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.

Exit mobile version